Edgewise Therapeutics, Inc.

This early-stage study is testing a single dose of an experimental drug called EDG-7500 in 32 adults. Some have mild or moderate liver problems, while others have normal liver function. Researchers want to see how the drug moves through the body and if it is safe in people with d…

This early-stage study is testing a new oral drug called EDG-15400 in 108 healthy adults aged 18 to 59. The main goal is to check if the drug is safe and how well it is tolerated, both after a single dose and after multiple doses. Researchers will also measure how much of the dru…